The effect of the stromal component of breast tumours on prediction of clinical outcome using gene expression microarray analysis.
about
Accurate prediction of response to endocrine therapy in breast cancer patients: current and future biomarkersPSMB7 is associated with anthracycline resistance and is a prognostic biomarker in breast cancerIntegrative computational biology for cancer researchBreast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.A self-directed method for cell-type identification and separation of gene expression microarrays.In silico estimates of tissue components in surgical samples based on expression profiling data.In silico ascription of gene expression differences to tumor and stromal cells in a model to study impact on breast cancer outcome.Statistical expression deconvolution from mixed tissue samples.Revisiting the technical validation of tumour biomarker assays: how to open a Pandora's box.Systematic bias in genomic classification due to contaminating non-neoplastic tissue in breast tumor samples.Differences in the transcriptional response to fulvestrant and estrogen deprivation in ER-positive breast cancerGene expression deconvolution in clinical samples.MMAD: microarray microdissection with analysis of differences is a computational tool for deconvoluting cell type-specific contributions from tissue samples.Prognostic stromal gene signatures in breast cancer.Profile of differentially expressed intratumoral cytokines to predict the immune-polarizing side effects of tamoxifen in breast cancer treatmentMicroarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction.Comparison of targeted next-generation sequencing and Sanger sequencing for the detection of PIK3CA mutations in breast cancerMolecular response to aromatase inhibitor treatment in primary breast cancer.Evaluation of the current knowledge limitations in breast cancer research: a gap analysisCharacteristics of cross-hybridization and cross-alignment of expression in pseudo-xenograft samples by RNA-Seq and microarraysMicroarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?Biomarkers in oncology drug developmentAnalysis of Altered Micro RNA Expression Profiles in Focal Cortical Dysplasia IIB.Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependencies.A sequential Monte Carlo approach to gene expression deconvolution.Gene expression profiling of response to mTOR inhibitor everolimus in pre-operatively treated post-menopausal women with oestrogen receptor-positive breast cancer.Thrombospondin-4 expression is activated during the stromal response to invasive breast cancer.Next-generation biobanking of metastases to enable multidimensional molecular profiling in personalized medicine.Gene expression in oligodendroglial tumors.
P2860
Q28069856-885D849B-B8FF-40C8-AB77-AB77C50A4438Q28267716-0DED1CDF-609D-40CD-A896-B4703D7786C7Q28744621-9B4DEF2B-43A9-46AE-A2B6-C26497187E56Q30245184-86BBD533-A4BF-49FB-A703-1B8AD384AE84Q31129201-8C90E96D-4C70-4BBB-B280-BC3CD6E9557EQ33642598-0EFD8CEB-7C9E-41B6-B8FA-E30FFB024485Q33761298-0D7EF67F-5DDD-42E0-8591-213F345148E1Q33785569-C0E075DD-98A6-4E8D-8244-6FF0424B4C37Q33876854-10BB6A4F-64AC-4A6E-8BC3-2D9ACF9D5DAFQ33947222-EB9F8B36-78BE-4BF9-933B-364895E36BBBQ33993400-4A33289E-FBC0-4FFC-A9A9-2100EBDE2C69Q34513150-490DB939-CF09-42DC-A8EC-24765A7A94F7Q35004287-2E94A86F-7FB9-4B7A-9918-C56CDB940AEEQ35180291-8C672C29-3243-4B4F-BDF6-042083A9C3F7Q35402584-5E53C775-84BD-4A1A-88ED-0D6DDCFEF3CFQ35558070-7D821D0C-F89C-484B-9A0A-BE107CB98332Q35846874-0F1D17BC-415B-4741-8283-AFC2BBB315EAQ35906338-3D16B417-40A2-45B9-9B91-AE87A03498FFQ36678664-A8EA3482-79CB-44BE-B155-CD9A9970F59EQ36885193-52CF4082-6F0C-4B01-8A96-CEAC41A657CFQ37356684-4C2989EF-5D20-432F-A2ED-1AB4E29D0D3CQ37453841-79EB87A5-DA62-4532-AF38-FAD3A9950A2CQ38456688-B43FB1ED-D5E5-4CD2-B73C-ACBAD2F2F3BFQ39207741-4B050405-3334-4FDF-944F-D06EADA072A6Q42695752-F22A087E-FADF-4F10-9E52-D3CB18A73115Q43060762-E7B5D632-DEA1-4F58-B214-363E5DA20B13Q45188502-AC63C7BD-1E72-45F4-883E-E45485FEAF39Q45788551-7CCA8D16-E538-424A-AD91-5EE1C357FBD8Q54368368-795DFB96-2AA2-4B49-9640-52F10A81E137
P2860
The effect of the stromal component of breast tumours on prediction of clinical outcome using gene expression microarray analysis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The effect of the stromal comp ...... xpression microarray analysis.
@ast
The effect of the stromal comp ...... xpression microarray analysis.
@en
type
label
The effect of the stromal comp ...... xpression microarray analysis.
@ast
The effect of the stromal comp ...... xpression microarray analysis.
@en
prefLabel
The effect of the stromal comp ...... xpression microarray analysis.
@ast
The effect of the stromal comp ...... xpression microarray analysis.
@en
P2093
P2860
P356
P1476
The effect of the stromal comp ...... xpression microarray analysis.
@en
P2093
Alan Mackay
Haukur Valgeirsson
Ian E Smith
Laura Fulford
Susan J Cleator
Tim Dexter
Trevor J Powles
P2860
P2888
P356
10.1186/BCR1506
P577
2006-06-21T00:00:00Z
P5875
P6179
1045496771